Journal of Tuberculosis and Lung Disease ›› 2025, Vol. 6 ›› Issue (1): 14-21.doi: 10.19983/j.issn.2096-8493.2024118
• Original Articles • Previous Articles Next Articles
Xu Yannan1, Fang Zihao1, Zhao Wenli1, Zheng Jiaxiong1, Liu Suyang1, Lin Jianxiong2, Ji Liwei2, Chang Qiaocheng1()
Received:
2024-07-14
Online:
2025-02-20
Published:
2025-02-20
Contact:
Chang Qiaocheng
E-mail:qcchang@stu.edu.cn
CLC Number:
Xu Yannan, Fang Zihao, Zhao Wenli, Zheng Jiaxiong, Liu Suyang, Lin Jianxiong, Ji Liwei, Chang Qiaocheng. Characterisation of isoniazid-resistant Mycobacterium tuberculosis mutations in China[J]. Journal of Tuberculosis and Lung Disease , 2025, 6(1): 14-21. doi: 10.19983/j.issn.2096-8493.2024118
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.jtbld.cn/EN/10.19983/j.issn.2096-8493.2024118
序号 | 文献来源 | 收集菌株年份 | 结核分枝杆菌数(株) | 耐INH菌株数(株) | 分子生物学检测技术 |
---|---|---|---|---|---|
1 | 杨映晖等[ | 2017—2018 | 411 | 138a | 基因芯片法、GeneXpertc |
2 | 王嫩寒等[ | 2021—2022 | 157 | 35b | MeltPro技术、Hain试验d |
3 | 吴联朋等[ | 2021—2022 | 54 | 45 | WGS |
4 | 蔡莺莺等[ | 2015—2020 | 482 | 127 | 芯片杂交法 |
5 | 赵竟男等[ | 2019 | 250 | 34 | PCR-线性杂交酶法 |
6 | 徐峰等[ | 2017—2018 | 2455 | 84 | PCR扩增 |
7 | 王伟等[ | 2016—2020 | 199 | 94 | Xpert MTB/RIF Ultra |
8 | 朱大冕等[ | 2014—2019 | 238 | 233 | PCR扩增 |
9 | 王菊红和穆丽平[ | 2019—2020 | 78 | 70 | 实时荧光定量PCR |
10 | 杨燕和张向荣[ | 2019—2021 | 1712 | 404 | 荧光PCR |
11 | Wang等[ | 2017—2018 | 137 | 81 | WGS |
12 | 秦翊翔等[ | 2017—2018 | 508 | 121 | WGS |
13 | 陈连勇等[ | 2016 | 846 | 146 | PCR扩增 |
14 | 赵刚等[ | 2016—2019 | 3317 | 197 | PCR扩增 |
15 | 文书等[ | 2015—2017 | 78 | 55 | PCR扩增 |
16 | 许河南等[ | 2019—2020 | 242 | 57 | 荧光PCR熔解曲线 |
17 | 蒋燕成等[ | 2019—2021 | 51 | 50 | DNA微阵列芯片法 |
18 | 穆成等[ | 2020 | 72 | 72 | WGS |
19 | 邓丽等[ | 2022 | 380 | 246 | PCR扩增 |
20 | Islam等[ | 2015—2017 | 206 | 191 | PCR扩增 |
21 | Zhdanova等[ | 2023 | 137 | 80 | WGS |
22 | Jia等[ | 2007—2016 | 913 | 264 | PCR扩增 |
总计 | - | - | 12923 | 2824 | - |
地区 | 菌株数 (株) | 构成比 (%) | 耐INH (株) | 构成比 (%) | katG基因a (株) | 构成比 (%) | inhA基因b (株) | 构成比 (%) |
---|---|---|---|---|---|---|---|---|
华北 | 90 | 0.69 | 31 | 1.08 | 29 | 1.35 | 2 | 0.46 |
华东 | 7755 | 60.00 | 1400 | 49.58 | 847 | 40.22 | 230 | 53.36 |
华中 | 277 | 2.14 | 156 | 5.53 | 121 | 5.75 | 25 | 5.80 |
华南 | 1996 | 15.45 | 623 | 22.06 | 401 | 19.04 | 113 | 26.22 |
西南 | 2805 | 21.71 | 614 | 21.75 | 708 | 33.62 | 61 | 14.16 |
合计 | 12923 | 100.00 | 2824 | 100.00 | 2106 | 100.00 | 431 | 100.00 |
突变基因 | 位点/密码子 | 氨基酸改变 | 菌株数(株) | 突变基因 | 位点/密码子 | 氨基酸改变 | 菌株数(株) |
---|---|---|---|---|---|---|---|
katG | 129 | Phe→Ser | 1 | inhA | -8T→A | - | 2 |
katG | 142GAC→GGC | Asn→Asp | 1 | inhA | -8T→C | - | 2 |
katG | 190CAG→UAG | Gln→SC | 1 | inhA | -9G→A | - | 1 |
katG | 232CCG→ACG | Pro→Thr | 1 | inhA | -15C→T | - | 323 |
katG | 285GGC→TGC | GIy→Cys | 1 | inhA | 24C→T | - | 1 |
katG | 289GAG→GGG | GIu→Gly | 1 | inhA | 93G→T | - | 1 |
katG | 300TGG→AGG | Trp→Arg | 1 | inhA | 154G→A | - | 1 |
katG | 315AGC→ACC | Ser→Thr | 1027 | inhA | 94UCG→GCG | Ser→Ala | 2 |
katG | 315AGC→AAC | Ser→Asn | 51 | inhA | 142GGU→AGU | Gly→Ser | 1 |
katG | 315AGC→ACA | Ser→Thr | 1 | inhA | 194AUG→ACC | Met→Thr | 1 |
katG | 315AGC→AGA | Ser→Arg | 2 | inhA | 194AUC→ACC | Ile→Thr | 1 |
katG | 315AGC→AUC | Ser→Lie | 3 | inhA | 其他b | - | 28 |
katG | 315AGC→CGC | Ser→Arg | 1 | ahpC | -47插入T | - | 3 |
katG | 315AGC→GGC | Ser→Gly | 2 | ahpC | -47G→A | - | 1 |
katG | 315AGC→AGU | Ser→Ser | 2 | ahpC | -48G→A | - | 6 |
katG | 315 | Ser→Thr | 486 | ahpC | -52C→T | - | 11 |
katG | 315 | Ser→Asn | 22 | ahpC | -52C→A | - | 2 |
katG | 315缺失 | - | 4 | ahpC | -54C→T | - | 4 |
katG | 316GGC→CGC | Gly→Arg | 1 | ahpC | -57C→T | - | 1 |
katG | 317 | Ile→Val | 1 | ahpC | 68C→T | - | 2 |
katG | 328UGG→UCG | Trp→Ser | 1 | ahpC | -74G→A | - | 2 |
katG | 333CUC→CCC | Leu→Arg | 1 | ahpC | -81C→T | - | 5 |
katG | 335AUC→ACC | Ile→Thr | 2 | ahpC | 481G→A | - | 6 |
katG | 419GAC→CAC | Asp→His | 180 | ahpC | 31CCC→CCU | Pro→Pro | 1 |
katG | 448GAC→GGC | Asp→Gly | 1 | ahpC | 106UUA→GUA | Leu→Val | 1 |
katG | 461CAG→CCG | GIn→Pro | 2 | ahpC | 其他c | - | 15 |
katG | 463CGG→CUG | Arg→Leu | 189 | ndh | 285UUG→CUG | Leu→Leu | 2 |
katG | 735GAC→GCC | Asp→AIa | 1 | ndh | 329UGG→UAG | Trp→stop | 1 |
katG | 1317AUC→GUC | Ile→Val | 1 | ndh | 339GGG→GCG | GIy→AIa | 1 |
katG | AAC→GAC | Asn→Phe | 1 | ndh | 364UAC→UAU | Tyr→Tyr | 1 |
katG | 129 | Asp→Ser | 1 | ndh | 399CGA→CGC | Arg→Arg | 1 |
katG | 138 | GIn→His | 1 | kasA | 121AGG-AAG | Arg→Lys | 1 |
katG | 09 | AlaI→Val | 1 | kasA | 164GUG→GUA | Val→Val | 2 |
katG | 缺失 | - | 1 | kasA | 252GCA→GUA | AIa→Val | 1 |
katG | 插入突变CG | - | 1 | kasA | 312GGC→AGC | GIy→Ser | 3 |
katG | 其他a | - | 170 | kasA | 404位后插入C | - | 2 |
katG+ahpC | - | - | 16 | kasA | 其他d | - | 3 |
katG+inhA | - | - | 58 | katG+katG | - | - | 10 |
其他组合e | - | - | 76 | 其他f | - | - | 52 |
耐药检测结果 | 菌株数(株) | 构成比(%) |
---|---|---|
产生耐药类型 | ||
野生型a | 153 | 5.42(153/2824) |
突变型 | 2638 | 93.41(2638/2824) |
其他b | 33 | 1.17(33/2824) |
异烟肼耐药类型 | ||
异烟肼单耐药 | 759 | 26.88(759/2824) |
非异烟肼耐药 | 2065 | 73.12(2065/2824) |
表型药敏与分子药敏结果相同 | 87.76(11251/12923) | |
表型耐药+分子耐药 | 2638 | |
表型敏感+分子敏感 | 8613 | |
表型药敏与分子药敏结果不同 | 5.20(627/12923) | |
表型耐药+分子敏感 | 186 | |
表型敏感+分子耐药 | 441 | |
其他c | 1045 | 8.09(1045/12923) |
[1] | 贾平平, 余利岩, 岑山. 结核分枝杆菌耐一线耐药基因突变及分子机制研究. 中国抗生素杂志, 2011, 36(7): 487-490. doi:10.3969/j.issn.1006-740X.2012.01.005. |
[2] | 张晨曦, 刘鼎阔. 细菌群集运动特性的研究进展. 生物工程学报, 2023, 39(8):3188-3203. doi:10.13345/j.cjb.220892. |
[3] |
Holzheimer M, Buter J, Minnaard AJ. Chemical Synthesis of Cell Wall Constituents of Mycobacterium tuberculosis. Chem Rev, 2021, 121(15): 9554-9643. doi:10.1021/acs.chemrev.
pmid: 34190544 |
[4] | 葛赛, 宋欣怡, 姜惠跃, 等. 结核分枝杆菌药物作用机理及耐药机制研究进展. 海南医学院学报, 2023, 29(24): 1904-1912. doi:10.13210/j.cnki.jhmu.20221128.002. |
[5] | 董思佳, 王毳. 谈耐多药结核病的防控进展与策略. 中国热带医学, 2021, 21(3):282-286. doi:10.13604/j.cnki.46-1064/r.2021.03.19. |
[6] | 龚兰, 牛群, 王楠, 等. 结核分枝杆菌异烟肼耐药基因突变与其他抗结核药物耐药的相关性. 实用医学杂志, 2023, 39(11): 1353-1358. doi:10.3969/j.issn.1006-5725.2023.11.006. |
[7] | World Health Organization. WHO global tuberculosis report. Geneva: World Health Organization, 2019. |
[8] | Gygli SM, Borrell S, Trauner A, et al. Antimicrobial resis-tance in Mycobacterium tuberculosis: mechanistic and evolutionary perspectives. FEMS Microbiol Rev, 2017, 41(3):354-373. doi:10.1093/femsre/fux011. |
[9] |
Dulberger CL, Rubin EJ, Boutte CC. The mycobacterial cell envelope-a moving target. Nat Rev Microbiol, 2020, 18(1):47-59. doi:10.1038/s41579-019-0273-7.
pmid: 31728063 |
[10] | 田丽, 周伟, 黄星, 等. 中国异烟肼耐药结核分枝杆菌基因突变特征分析. 中国防痨杂志, 2022, 44(4):354-361. doi:10.19982/j.issn.1000-6621.20210573. |
[11] | 杨映晖, 伍定辉, 苏伟明, 等. 基因芯片法在结核分枝杆菌耐药基因快速诊断中的应用价值. 中国防痨杂志, 2020, 42(11):1191-1195. doi:10.3969/j.issn.1000-6621.2020.11.009. |
[12] | 王嫩寒, 赵琰枫, 田丽丽, 等. 荧光PCR探针熔解曲线技术检测痰标本中结核分枝杆菌异烟肼耐药性的研究. 实用医学杂志, 2023, 39(20):2664-2670. doi:10.19982/j.issn.1000-6621.20230086. |
[13] | 吴联朋, 徐克, 何贵清. 温州市耐多药/利福平耐药结核分枝杆菌耐药基因突变及特征分析. 温州医科大学学报, 2023, 53(4):305-310. doi:10.3784/j.issn.1003-9961.2014.04.014. |
[14] | 蔡莺莺, 石庆新, 周秋菊, 等. 台州地区结核分枝杆菌利福平和异烟肼耐药基因的流行病学调查. 中国现代医生, 2021, 59(20):146-149. |
[15] | 赵竟男, 江友桥, 伍文华, 等. 江西省3个监测点结核分枝杆菌耐药性及耐药基因检测分析. 疾病监测, 2022, 37(1):127-131. doi:10.3784/jbjc.202107140397. |
[16] | 徐峰, 饶跃峰, 张幸国, 等. 宁波地区结核分枝杆菌基因突变位点确证及与异烟肼、利福平耐药关系研究. 中国现代应用药学, 2020, 37(20):2511-2515. doi:10.13748/j.cnki.issn1007-7693.2020.20.014. |
[17] | 王伟, 李静, 郭琪, 等. 耐异烟肼结核分枝杆菌的基因突变类型及表型异质性研究. 中国卫生检验杂志, 2021, 31(22):2744-2746. |
[18] | 朱大冕, 刘文果, 沈静, 等. 重庆地区结核分枝杆菌异烟肼和丙硫异烟胺耐药及其交叉耐药相关基因突变研究. 中国人兽共患病学报, 2022, 38(5):405-409. doi:10.3969/j.issn.1002-2694.2022.00.047. |
[19] | 王菊红, 穆丽平. 耐多药结核分枝杆菌异烟肼和利福平耐药相关基因突变特征观察. 内蒙古医学杂志, 2022, 54(8):988-990. doi:10.16096/J.cnki.nmgyxzz.2022.54.08.026. |
[20] | 杨燕, 张向荣. 结核分枝杆菌异烟肼耐药基因突变与耐药水平的相关性研究. 南京医科大学学报(自然科学版), 2023, 43(3):392-396. |
[21] | Wang L, Yang J, Chen L, et al. Whole-genome sequencing of Mycobacterium tuberculosis for prediction of drug resistance. Epidemiol Infect, 2022, 150:22. doi:10.1016/s1473-3099(15)00062-6. |
[22] | 秦翊翔, 蓝如束, 覃慧芳, 等. 广西壮族自治区结核分枝杆菌异烟肼与利福平耐药基因联合突变特征分析. 疾病监测, 2022, 37(6):787-791. doi:10.3784/jbjc.202112120636. |
[23] | 陈连勇, 茹浩浩, 杨星, 等. 云南省异烟肼耐药结核分枝杆菌katG和inhA基因突变特征. 昆明医科大学学报, 2022, 43(8):28-33. doi:10.12259/j.issn.2095-610X.S20220803. |
[24] | 赵刚, 贾庆军, 吴亦斐, 等. 浙江地区耐多药结核分枝杆菌基因突变特征分析. 中华疾病控制杂志, 2021, 25(1):66-71. doi:10.16462/j.cnki.zhjbkz.2021.01.013. |
[25] | 文书, 林璋礼, 刘丁发, 等. 耐异烟肼结核分枝杆菌及其katG、inhA基因的突变. 中国热带医学, 2019, 19(8):723-726. doi:10.13604/j.cnki.46-1064/r.2019.08.03. |
[26] | 许河南, 杨红慧, 赖聪娟, 等. 浙江省丽水市结核分枝杆菌临床分离株耐药性及基因突变情况. 疾病监测, 2023, 38(1):51-56. doi:10.3784/jbjc.202205260243. |
[27] | 蒋燕成, 张建明, 陈紫萱, 等. 结核分枝杆菌耐药基因突变特征及与耐药水平关系的研究. 检验医学与临床, 2023, 20(15):2145-2148. doi:10.3969/j.issn.1672-9455.2023.15.001. |
[28] | 穆成, 孙蕊, 王志锐, 等. 基于全基因组测序的72株耐多药结核分枝杆菌耐药基因突变特征分析. 中国热带医学, 2023, 23(7):725-729,741. doi:10.13604/j.cnki.46-1064/r.2023.07.09. |
[29] | 邓丽, 王楠, 雷杰, 等. 华南地区380株结核分枝杆菌异烟肼耐药基因突变情况分析. 国际医药卫生导报, 2023, 29(5):614-618. doi:10.3760/cma.j.issn.1007-1245.2023.05.005. |
[30] | Islam MM, Tan Y, Hameed HMA, et al. Detection of novel mutations associated with independent resistance and cross-resistance to isoniazid and prothionamide in Mycobacterium tuberculosis clinical isolates. Clin Microbiol Infect, 2019, 25(8):1041.e1-1041.e7. doi:10.1016/j.cmi.2018.12.008. |
[31] | Zhdanova S, Jiao WW, Sinkov V, et al. Insight into Population Structure and Drug Resistance of Pediatric Tuberculosis Strains from China and Russia Gained through Whole-Genome Sequencing. Int J Mol Sci, 2023, 24(12):10302. doi:10.3390/ijms241210302. |
[32] | Jia H, Xu Y, Sun Z. Analysis on Drug-Resistance-Associated Mutations among Multidrug-Resistant Mycobacterium tuberculosis Isolates in China. Antibiotics (Basel), 2021, 10(11):1367. doi:10.3390/antibiotics10111367. |
[33] | 罗红丽, 庞蕾, 谢建平. 分枝杆菌枝菌酸合成及其调控. 微生物学报, 2012, 52(2):146-151. doi:10.13343/j.cnki.wsxb.2012.02.011. |
[34] |
Oudghiri A, Karimi H, Chetioui F, et al. Molecular characterization of mutations associated with resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients from high prevalence tuberculosis city in Morocco. BMC Infect Dis, 2018, 18(1):98. doi:10.1186/s12879-018-3009-9.
pmid: 29486710 |
[35] |
Chiaradia L, Lefebvre C, Parra J, et al. Dissecting the mycobacterial cell envelope and defining the composition of the native mycomembrane. Sci Rep, 2017, 7(1):12807. doi:10.1038/s41598-017-12718-4.
pmid: 28993692 |
[36] | Marrakchi H, Lanéelle MA, Daffé M. Mycolic acids: structures, biosynthesis, and beyond. Chem Biol, 2014, 21(1):67-85. doi:10.1016/j.chembiol.2013.11.011. |
[37] | Cole S, Brosch R, Parkhill J, et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature, 1998, 393(6685):537-544. doi:10.1038/31159. |
[38] | 石大伟. 河南省耐多药结核分枝杆菌耐药相关基因的分子流行病学研究. 郑州:中国医学科学院病原生物学研究所, 2011. |
[1] | Chen Yu, Li Xiaorui, Wang Miaoran, Zhang Yuqi, Liu Chang, Wang Zhaohua, Shi Jie, Fan Lichao, Yin Zhihua, Xie Jianping. The research progress on the role of metal ions in tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 102-112. |
[2] | Gu Jinhua, Zhang Panpan. Evaluation of the application value of three detection methods for Mycobacterium tuberculosis in a comprehensive hospital [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 68-72. |
[3] | Wu Xiucen, Chen Guihua. Interpretation of the 2023 U.S. Preventive Clinical Services Guidelines Workgroup Statement of Recommendations for Screening Adults for Latent Tuberculosis Infection [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(5): 398-403. |
[4] | Xiong Yan, Xiao Yue, Chen Chuang, Xia Yong, Li Yunkui, Lu Jia, Xia Lan. Analysis of tuberculosis screening results among college freshmen in Sichuan Province in 2023 [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(5): 422-429. |
[5] | Sun Bo, Feng Liping, Teng Chong, Zhu Hanfang, Zhao Bing, Feng Tao, Wang Qingkui, Zhou Hao, Gao Xinghai, Ou Xichao. Analysis of features of drug resistance of Mycobacterium tuberculosis and risk factors of multidrug-resistance in Hinggan League of Inner Mongolia Autonomous Region, 2021—2023 [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(5): 437-444. |
[6] | Zhang Jie, Ding Beichuan, Ren Yixuan, Tian Lili, Yi Junli, Pang Mengdi, Yang Xinyu. Exploring the causes of recurrence and genetic characteristics of tuberculosis strains in Beijing based on genotypic analysis [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(2): 128-134. |
[7] | Liang Chen, Tang Shenjie, Lin Minggui. Research progress of comprehensive treatment for tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(1): 70-80. |
[8] | iu Liming, Li Ming. New progress in research on the influencing factors of the severity of Mycoplasma pneumoniae pneumonia in children [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(1): 81-87. |
[9] | Xu Yujing, Li Yuru, Tang Lingling. Evaluation of the application effect of diversified missionary nursing on multidrug-resistant pulmonary tuberculosis patients [J]. Journal of Tuberculosis and Lung Disease, 2023, 4(6): 449-453. |
[10] | Wang Danfeng, Du Guichun. Evaluation of focused nursing care on treatment compliance and prognosis of drug-resistant pulmonary tuberculosis patients [J]. Journal of Tuberculosis and Lung Disease, 2023, 4(6): 454-456. |
[11] | You Guoqing, Liu Wenguo, Feng Xin, Yu Min, Shi Lin, Hu Yan. Analysis of fluoroquinolones resistance in multidrug-resistant tuberculosis patients in Chongqing from 2020 to 2022 [J]. Journal of Tuberculosis and Lung Disease, 2023, 4(6): 475-479. |
[12] | Yan Yaru, Xie Jianping. Research progress on the role of interleukin-1 in immune response and metabolic reprogramming of macrophages against Mycobacterium tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2023, 4(6): 511-518. |
[13] | Zhong Miner, Du Yuhua, Zhang Danni, Lin Ying, Wu Guifeng, Wang Ting, Liu Jianxiong. Analysis of latent tuberculosis infection among middle school and university freshmen in Guangzhou from 2018 to 2021 [J]. Journal of Tuberculosis and Lung Disease, 2023, 4(2): 115-119. |
[14] | Luo Yi, Tao Fengxi, Li Guofei, Zhang Huihui, Peng Peng, Ren Yi, Liu Suyang. Environmental monitoring and analysis of Mycobacterium tuberculosis and discussion on the effect of disinfection equipment in a tuberculosis hospital [J]. Journal of Tuberculosis and Lung Disease, 2023, 4(2): 135-140. |
[15] | Yang Cui, Li Yuan, He Zhentao, Xu Jiaxing, Yu Xiaoying, Lu Chengyu, Chen Dehui, Zhai Yingying. Primary ciliary dyskinesia for DNAAF3 gene mutations: a case report and literature review [J]. Journal of Tuberculosis and Lung Disease, 2023, 4(2): 147-152. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||